Journal ArticleOPEN ACCESS

Future therapies: Early trials and basic science

Journal of the Canadian Urological Association (2013) 7(9-10 SUPPL4)
DOI: 10.5489/cuaj.1617
1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Pharmacotherapeutic options for overactive bladder (OAB) include antimuscarinics and the beta3-adrenoceptor agonist mirabegron. Research and development of novel therapeutic options for OAB continues to be an active field. This review summarizes recent research with the existing therapies as well as the most promising agents in development. © 2013 Canadian Urological Association.

Cite

CITATION STYLE

APA

Andersson, K. E. (2013). Future therapies: Early trials and basic science. Journal of the Canadian Urological Association, 7(9-10 SUPPL4). https://doi.org/10.5489/cuaj.1617

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free